In conclusion, our study shows that mitotic kinesins are potential therapeutic vulnerabilities for MPNSTs and demonstrates that the combined suppression of KIF11 and KIF15 together with BRD4 inhibition exhibit in vitro synergistic antitumoral effects in MPNST cells. This evidence concerns the gene KIF15 and malignant peripheral nerve sheath tumor.